Form EFFECT Sunshine Biopharma Inc.
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | May 18, 2026 11:00 A.M. |
| Form: | S-1 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- H3 Zoom Closes Oversubscribed USD$3.6 Million Series A Round to Scale AI-Powered Inspection Intelligence Across Asia
- CSG showcased new projects, partnerships and key portfolio products at Eurosatory 2026
- Retailers Lose £29 Million to Returns Fraud Across 1 Million Orders, as New ReBound Data Reveals Industry "Blind Spot"
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share